A highly conserved aspartic acid residue in the signature disulfide loop of the α1 subunit is a determinant of gating in the glycine receptor

被引:47
作者
Schofield, CM
Jenkins, A
Harrison, NL
机构
[1] Cornell Univ, Weill Med Coll, Dept Anesthesiol, CV Starr Lab Mol Neuropharmacol, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, Grad Program Neurosci, New York, NY 10021 USA
[4] Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M302416200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ligand-gated ion channels (LGICs) mediate rapid chemical neurotransmission. This gene superfamily includes the nicotinic acetylcholine, GABA(A/C), 5-hydroxytryptamine type 3, and glycine receptors. A signature disulfide loop (Cys loop) in the extracellular domain is a structural motif common to all LGIC member subunits. Here we report that a highly conserved aspartic acid residue within the Cys loop at position 148 (Asp-148) of the glycine receptor alpha1 subunit is critical in the process of receptor activation. Mutation of this acidic residue to the basic amino acid lysine produces a large decrease in the potency of glycine, produces a decrease in the Hill slope, and converts taurine from a full agonist to a partial agonist; these data are consistent with a molecular defect in the receptor gating mechanism. Additional mutation of Asp-148 shows that alterations in the EC50 for agonists are dependent upon the charge of the side chain at this position and not molecular volume, polarity, or hydropathy. This study implicates negative charge at position Asp-148 as a critical component of the process in which agonist binding is coupled to channel gating. This finding adds to an emerging body of evidence supporting the involvement of the Cys loop in the gating mechanism of the LGICs.
引用
收藏
页码:34079 / 34083
页数:5
相关论文
共 23 条
[1]  
AMIN J, 1994, MOL PHARMACOL, V45, P317
[2]   RESIDUES WITHIN TRANSMEMBRANE SEGMENT M2 DETERMINE CHLORIDE CONDUCTANCE OF GLYCINE RECEPTOR HOMO-OLIGOMERS AND HETEROOLIGOMERS [J].
BORMANN, J ;
RUNDSTROM, N ;
BETZ, H ;
LANGOSCH, D .
EMBO JOURNAL, 1993, 12 (10) :3729-3737
[3]  
Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO
[4]  
2-7
[5]   Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors [J].
Brejc, K ;
van Dijk, WJ ;
Klaassen, RV ;
Schuurmans, M ;
van der Oost, J ;
Smit, AB ;
Sixma, TK .
NATURE, 2001, 411 (6835) :269-276
[6]   MODELING OF AGONIST BINDING TO THE LIGAND-GATED ION CHANNEL SUPERFAMILY OF RECEPTORS [J].
COCKCROFT, VB ;
OSGUTHORPE, DJ ;
BARNARD, EA ;
LUNT, GG .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1990, 8 (04) :386-397
[7]  
Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924
[8]   Neurobiology - Snails, synapses and smokers [J].
Dougherty, DA ;
Lester, HA .
NATURE, 2001, 411 (6835) :252-254
[9]   Analysis of GLRA1 in hereditary and sporadic hyperekplexia: A novel mutation in a family cosegregating for hyperekplexia and spastic paraparesis [J].
Elmslie, FV ;
Hutchings, SM ;
Spencer, V ;
Curtis, A ;
Covanis, T ;
Gardiner, RM ;
Rees, M .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (05) :435-436
[10]   Molecular determinants of glycine receptor subunit assembly [J].
Griffon, N ;
Büttner, C ;
Nicke, A ;
Kuhse, J ;
Schmalzing, G ;
Betz, H .
EMBO JOURNAL, 1999, 18 (17) :4711-4721